Aea.ltd
SPONSOR
How does tirzepatide works?
Tirzepatide works by acting as a dual agonist for two important hormone receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones are naturally produced in the body and play key roles in regulating blood sugar levels and metabolism.
1.Stimulation of Insulin Release: Tirzepatide activates the GIP receptor and the GLP-1 receptor, both of which are located on pancreatic beta cells. Activation of these receptors stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps cells take up glucose from the bloodstream, reducing blood sugar levels.
2.Inhibition of Glucagon Release: Tirzepatide also inhibits the release of glucagon, another hormone produced by the pancreas. Glucagon raises blood sugar levels by promoting the release of stored glucose from the liver. By reducing glucagon release, tirzepatide helps prevent excessive glucose production.
3.Appetite Regulation and Gastric Emptying: GLP-1 receptors are also found in areas of the brain involved in appetite regulation. Activation of these receptors by tirzepatide can help reduce food intake and promote a feeling of fullness. Additionally, GLP-1 slows down gastric emptying, which can help control the rate at which nutrients, including glucose, are absorbed into the bloodstream after eating.
4.Weight Loss: Tirzepatide’s dual agonist action on both GIP and GLP-1 receptors has been associated with significant weight loss. It may work by modulating fat utilization and promoting a sense of fullness, leading to reduced calorie intake and increased energy expenditure.
By activating GIP and GLP-1 receptors, tirzepatide addresses multiple aspects of blood sugar regulation, insulin release, glucagon inhibition, and appetite control.
Tirzepatide is in stock now and can be shipped at any time. Personal use, resell, research etc. will be supported!
Tirzepatide Stock：5mg/vial; 10mg/vial; 15mg/vial
Other specifications can be customized
For more details, contact us:
Email: Ella@aasraw.com
1.Stimulation of Insulin Release: Tirzepatide activates the GIP receptor and the GLP-1 receptor, both of which are located on pancreatic beta cells. Activation of these receptors stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps cells take up glucose from the bloodstream, reducing blood sugar levels.
2.Inhibition of Glucagon Release: Tirzepatide also inhibits the release of glucagon, another hormone produced by the pancreas. Glucagon raises blood sugar levels by promoting the release of stored glucose from the liver. By reducing glucagon release, tirzepatide helps prevent excessive glucose production.
3.Appetite Regulation and Gastric Emptying: GLP-1 receptors are also found in areas of the brain involved in appetite regulation. Activation of these receptors by tirzepatide can help reduce food intake and promote a feeling of fullness. Additionally, GLP-1 slows down gastric emptying, which can help control the rate at which nutrients, including glucose, are absorbed into the bloodstream after eating.
4.Weight Loss: Tirzepatide’s dual agonist action on both GIP and GLP-1 receptors has been associated with significant weight loss. It may work by modulating fat utilization and promoting a sense of fullness, leading to reduced calorie intake and increased energy expenditure.
By activating GIP and GLP-1 receptors, tirzepatide addresses multiple aspects of blood sugar regulation, insulin release, glucagon inhibition, and appetite control.
Tirzepatide is in stock now and can be shipped at any time. Personal use, resell, research etc. will be supported!
Tirzepatide Stock：5mg/vial; 10mg/vial; 15mg/vial
Other specifications can be customized
For more details, contact us:
Email: Ella@aasraw.com
